By Deena Beasley and Julie Steenhuysen (Reuters) -Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a class being used by ...
The rapid and sustained effects of Tazbentetol on clinical outcome measures are consistent with findings from a NIH-supported, published Alzheimer's mouse model study where synapse loss in the ...
LONDON/COPENHAGEN (Reuters) -Novo Nordisk's closely-watched Alzehimer's trials - which failed on Monday to show it can slow the disease’s progression - were always a long-shot, although they had ...
The Texas Tribune on MSN
How Texas’ voter-approved $3 billion dementia fund will fare in court
In 2023, Texas overcame lawsuits that sought to prevent constitutional amendments from going into effect, but one that voters ...
Charlie Quirke has raised over £177,000 for Alzheimer's Research UK after completing a five-day Trek for a Cure retracing his ...
Initially, it was simple forgetfulness, not being able to recall names of people or certain objects, but then driving anywhere became a nightmare. I was getting totally lost even going to places I’ve ...
News-Medical.Net on MSN
Epstein family support accelerates USC’s mission to end Alzheimer’s
The USC Alzheimer's Therapeutic Research Institute will be renamed the USC Epstein Family Alzheimer's Therapeutic Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback